Clinical Trial Update: Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating rosuvastatin for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Diabetes Mellitus, Chronic Kidney Disease | Phase 4 | Status: COMPLETED